Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	cardiac muscle thin filament assembly	NRAP NEB	4.56e-05	3	81	2	GO:0071691
GeneOntologyBiologicalProcess	maintenance of cell number	KLF10 KDM4C MED14 SMARCA2 SMARCA4 FGFR1 EZH2	4.66e-05	242	81	7	GO:0098727
GeneOntologyBiologicalProcess	regulation of organelle organization	ALMS1 RHPN2 SYNE2 SYNPO2L SMARCA2 RHPN2P1 SMARCA4 PAM FGFR1 NEB DNAI3 SMCR8 DYNC1H1 INPP5J NSMCE1 DDX11	5.65e-05	1342	81	16	GO:0033043
GeneOntologyBiologicalProcess	phosphocreatine metabolic process	CKMT2 CKMT1A	1.51e-04	5	81	2	GO:0006603
GeneOntologyBiologicalProcess	phosphagen biosynthetic process	CKMT2 CKMT1A	1.51e-04	5	81	2	GO:0042396
GeneOntologyBiologicalProcess	phosphocreatine biosynthetic process	CKMT2 CKMT1A	1.51e-04	5	81	2	GO:0046314
GeneOntologyBiologicalProcess	phosphagen metabolic process	CKMT2 CKMT1A	1.51e-04	5	81	2	GO:0006599
GeneOntologyCellularComponent	Z disc	NRAP SYNE2 SYNPO2L NEB PDLIM5	3.03e-04	151	81	5	GO:0030018
GeneOntologyCellularComponent	I band	NRAP SYNE2 SYNPO2L NEB PDLIM5	4.68e-04	166	81	5	GO:0031674
GeneOntologyCellularComponent	bBAF complex	SMARCA2 SMARCA4	6.54e-04	10	81	2	GO:0140092
GeneOntologyCellularComponent	sperm principal piece	FSIP2 CATSPERE C2CD6	6.62e-04	44	81	3	GO:0097228
GeneOntologyCellularComponent	chromosome, centromeric region	PDS5B KDM4C SMARCA4 PDS5A EZH2 NSMCE1	7.11e-04	276	81	6	GO:0000775
GeneOntologyCellularComponent	TRAPPIII protein complex	TRAPPC8 TRAPPC2L	9.54e-04	12	81	2	GO:1990072
GeneOntologyCellularComponent	npBAF complex	SMARCA2 SMARCA4	1.31e-03	14	81	2	GO:0071564
GeneOntologyCellularComponent	GBAF complex	SMARCA2 SMARCA4	1.31e-03	14	81	2	GO:0140288
GeneOntologyCellularComponent	CatSper complex	CATSPERE C2CD6	1.51e-03	15	81	2	GO:0036128
GeneOntologyCellularComponent	nBAF complex	SMARCA2 SMARCA4	1.72e-03	16	81	2	GO:0071565
GeneOntologyCellularComponent	TRAPP complex	TRAPPC8 TRAPPC2L	1.94e-03	17	81	2	GO:0030008
Domain	SnAC	SMARCA2 SMARCA4	1.81e-05	2	80	2	SM01314
Domain	Gln-Leu-Gln_QLQ	SMARCA2 SMARCA4	1.81e-05	2	80	2	IPR014978
Domain	SnAC	SMARCA2 SMARCA4	1.81e-05	2	80	2	IPR029295
Domain	SnAC	SMARCA2 SMARCA4	1.81e-05	2	80	2	PF14619
Domain	QLQ	SMARCA2 SMARCA4	1.81e-05	2	80	2	SM00951
Domain	QLQ	SMARCA2 SMARCA4	1.81e-05	2	80	2	PS51666
Domain	QLQ	SMARCA2 SMARCA4	1.81e-05	2	80	2	PF08880
Domain	NEBU	NRAP NEB	1.08e-04	4	80	2	SM00227
Domain	Nebulin	NRAP NEB	1.08e-04	4	80	2	PF00880
Domain	HSA	SMARCA2 SMARCA4	1.08e-04	4	80	2	SM00573
Domain	Nebulin	NRAP NEB	1.08e-04	4	80	2	IPR013998
Domain	NEBULIN	NRAP NEB	1.08e-04	4	80	2	PS51216
Domain	Nebulin_repeat	NRAP NEB	1.08e-04	4	80	2	IPR000900
Domain	HSA	SMARCA2 SMARCA4	1.08e-04	4	80	2	PS51204
Domain	HSA_dom	SMARCA2 SMARCA4	1.08e-04	4	80	2	IPR014012
Domain	HSA	SMARCA2 SMARCA4	1.08e-04	4	80	2	PF07529
Domain	BRK	SMARCA2 SMARCA4	2.69e-04	6	80	2	SM00592
Domain	BRK_domain	SMARCA2 SMARCA4	2.69e-04	6	80	2	IPR006576
Domain	BRK	SMARCA2 SMARCA4	2.69e-04	6	80	2	PF07533
Domain	LIM	NRAP FHL1 PDLIM5	3.24e-03	69	80	3	PF00412
Domain	-	NRAP FHL1 PDLIM5	3.37e-03	70	80	3	2.10.110.10
Domain	Znf_LIM	NRAP FHL1 PDLIM5	3.51e-03	71	80	3	IPR001781
Domain	LIM_DOMAIN_1	NRAP FHL1 PDLIM5	3.51e-03	71	80	3	PS00478
Domain	LIM_DOMAIN_2	NRAP FHL1 PDLIM5	3.51e-03	71	80	3	PS50023
Domain	LIM	NRAP FHL1 PDLIM5	3.51e-03	71	80	3	SM00132
Domain	PDZ	RHPN2 SYNPO2L AFDN PDLIM5	3.76e-03	148	80	4	SM00228
Domain	-	RHPN2 SYNPO2L AFDN PDLIM5	3.94e-03	150	80	4	2.30.42.10
Domain	PDZ	RHPN2 SYNPO2L AFDN PDLIM5	4.03e-03	151	80	4	PS50106
Domain	PDZ	RHPN2 SYNPO2L AFDN PDLIM5	4.13e-03	152	80	4	IPR001478
Domain	ADAM_spacer1	ADAMTS7 ADAMTS9	4.32e-03	23	80	2	IPR010294
Domain	ADAM_spacer1	ADAMTS7 ADAMTS9	4.32e-03	23	80	2	PF05986
Domain	Peptidase_M12B_ADAM-TS	ADAMTS7 ADAMTS9	4.70e-03	24	80	2	IPR013273
Domain	Bromodomain_CS	SMARCA2 SMARCA4	5.51e-03	26	80	2	IPR018359
Domain	SNF2_N	SMARCA2 SMARCA4	8.27e-03	32	80	2	IPR000330
Domain	SNF2_N	SMARCA2 SMARCA4	8.27e-03	32	80	2	PF00176
Pubmed	Selective Killing of SMARCA2- and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models.	SMARCA2 SMARCA4 EZH2	1.26e-08	3	82	3	28292935
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	PDS5B NBAS FBLN1 RAD18 SH2D4A L3MBTL2 SMARCA2 SMARCA4 XDH PDS5A RRBP1 DYNC1H1 PCMT1 NSMCE1	4.92e-07	1155	82	14	20360068
Pubmed	New insights into BS69 functions.	SMARCA2 SMARCA4 EZH2	7.01e-07	8	82	3	16565076
Pubmed	Human transcription factor protein interaction networks.	HDAC3 RAD18 KLF10 ALMS1 ZFHX4 L3MBTL2 USP9X SYNE2 MC1R SMARCA2 SMARCA4 PDS5A FHL1 DYNC1H1 PCMT1	1.12e-06	1429	82	15	35140242
Pubmed	Protein interaction studies in human induced neurons indicate convergent biology underlying autism spectrum disorders.	SMARCA2 SMARCA4 RRBP1 DYNC1H1	3.30e-06	43	82	4	36950384
Pubmed	Identification of actionable targets for breast cancer intervention using a diversity outbred mouse model.	PDS5B KLF10	5.49e-06	2	82	2	36968078
Pubmed	The hbrm and BRG-1 proteins, components of the human SNF/SWI complex, are phosphorylated and excluded from the condensed chromosomes during mitosis.	SMARCA2 SMARCA4	5.49e-06	2	82	2	8670841
Pubmed	Lung cancer with loss of BRG1/BRM, shows epithelial mesenchymal transition phenotype and distinct histologic and genetic features.	SMARCA2 SMARCA4	5.49e-06	2	82	2	23163725
Pubmed	A close correlation in the expression patterns of Af-6 and Usp9x in Sertoli and granulosa cells of mouse testis and ovary.	USP9X AFDN	5.49e-06	2	82	2	15509704
Pubmed	Combined gene dosage requirement for SWI/SNF catalytic subunits during early mammalian development.	SMARCA2 SMARCA4	5.49e-06	2	82	2	23076393
Pubmed	Differential preimplantation regulation of two mouse homologues of the yeast SWI2 protein.	SMARCA2 SMARCA4	5.49e-06	2	82	2	9603422
Pubmed	The SWI/SNF chromatin remodeling protein Brg1 is required for vertebrate neurogenesis and mediates transactivation of Ngn and NeuroD.	SMARCA2 SMARCA4	5.49e-06	2	82	2	15576411
Pubmed	PDS5A and PDS5B differentially affect gene expression without altering cohesin localization across the genome.	PDS5B PDS5A	5.49e-06	2	82	2	35986423
Pubmed	SWI/SNF gene variants and glioma risk and outcome.	SMARCA2 SMARCA4	5.49e-06	2	82	2	23276717
Pubmed	Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.	SMARCA2 SMARCA4	5.49e-06	2	82	2	27097303
Pubmed	Chromatin remodeling factors and BRM/BRG1 expression as prognostic indicators in non-small cell lung cancer.	SMARCA2 SMARCA4	5.49e-06	2	82	2	15240517
Pubmed	Concomitant loss of SMARCA2 and SMARCA4 expression in small cell carcinoma of the ovary, hypercalcemic type.	SMARCA2 SMARCA4	5.49e-06	2	82	2	26564006
Pubmed	SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction.	SMARCA2 SMARCA4	5.49e-06	2	82	2	33027072
Pubmed	SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.	SMARCA2 SMARCA4	5.49e-06	2	82	2	28038711
Pubmed	A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.	SMARCA2 SMARCA4	5.49e-06	2	82	2	23872584
Pubmed	Proinflammatory stimuli engage Brahma related gene 1 and Brahma in endothelial injury.	SMARCA2 SMARCA4	5.49e-06	2	82	2	23963727
Pubmed	PDS5 proteins are required for proper cohesin dynamics and participate in replication fork protection.	PDS5B PDS5A	5.49e-06	2	82	2	31757807
Pubmed	SW13 cells can transition between two distinct subtypes by switching expression of BRG1 and Brm genes at the post-transcriptional level.	SMARCA2 SMARCA4	5.49e-06	2	82	2	12493776
Pubmed	Heterozygous Mutations in SMARCA2 Reprogram the Enhancer Landscape by Global Retargeting of SMARCA4.	SMARCA2 SMARCA4	5.49e-06	2	82	2	31375262
Pubmed	Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.	SMARCA2 SMARCA4	5.49e-06	2	82	2	23088494
Pubmed	Repression of myoblast proliferation and fibroblast growth factor receptor 1 promoter activity by KLF10 protein.	KLF10 FGFR1	5.49e-06	2	82	2	23569208
Pubmed	Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.	SMARCA2 SMARCA4	5.49e-06	2	82	2	17075831
Pubmed	The Ras target AF-6 is a substrate of the fam deubiquitinating enzyme.	USP9X AFDN	5.49e-06	2	82	2	9722616
Pubmed	SWI/SNF chromatin remodeling enzyme ATPases promote cell proliferation in normal mammary epithelial cells.	SMARCA2 SMARCA4	5.49e-06	2	82	2	20333683
Pubmed	SWI/SNF Complex-deficient Undifferentiated Carcinoma of the Gastrointestinal Tract: Clinicopathologic Study of 30 Cases With an Emphasis on Variable Morphology, Immune Features, and the Prognostic Significance of Different SMARCA4 and SMARCA2 Subunit Deficiencies.	SMARCA2 SMARCA4	5.49e-06	2	82	2	34812766
Pubmed	Usp9y (ubiquitin-specific protease 9 gene on the Y) is associated with a functional promoter and encodes an intact open reading frame homologous to Usp9x that is under selective constraint.	USP9X USP9Y	5.49e-06	2	82	2	12925892
Pubmed	Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non-Small Cell Lung Carcinoma.	SMARCA2 SMARCA4	5.49e-06	2	82	2	32855269
Pubmed	Targeting of BRM Sensitizes BRG1-Mutant Lung Cancer Cell Lines to Radiotherapy.	SMARCA2 SMARCA4	5.49e-06	2	82	2	30478150
Pubmed	Downregulation of SWI/SNF chromatin remodeling factor subunits modulates cisplatin cytotoxicity.	SMARCA2 SMARCA4	5.49e-06	2	82	2	22721696
Pubmed	Ubiquitin-specific protease activity of USP9Y, a male infertility gene on the Y chromosome.	USP9X USP9Y	5.49e-06	2	82	2	12895410
Pubmed	Chromatin remodeling complexes interact dynamically with a glucocorticoid receptor-regulated promoter.	SMARCA2 SMARCA4	5.49e-06	2	82	2	18508913
Pubmed	Compensation of BRG-1 function by Brm: insight into the role of the core SWI-SNF subunits in retinoblastoma tumor suppressor signaling.	SMARCA2 SMARCA4	5.49e-06	2	82	2	11719516
Pubmed	PDS5A and PDS5B in Cohesin Function and Human Disease.	PDS5B PDS5A	5.49e-06	2	82	2	34070827
Pubmed	The SWI/SNF ATPases Are Required for Triple Negative Breast Cancer Cell Proliferation.	SMARCA2 SMARCA4	5.49e-06	2	82	2	25808524
Pubmed	Antagonistic roles for BRM and BRG1 SWI/SNF complexes in differentiation.	SMARCA2 SMARCA4	5.49e-06	2	82	2	19144648
Pubmed	DNA binding drives the association of BRG1/hBRM bromodomains with nucleosomes.	SMARCA2 SMARCA4	5.49e-06	2	82	2	28706277
Pubmed	[Expression of BRG1 and BRM proteins in prostatic cancer].	SMARCA2 SMARCA4	5.49e-06	2	82	2	21092585
Pubmed	High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer.	SMARCA2 SMARCA4	5.49e-06	2	82	2	29391527
Pubmed	Expression of SMARCA2 and SMARCA4 in gastric adenocarcinoma and construction of a nomogram prognostic model.	SMARCA2 SMARCA4	5.49e-06	2	82	2	37634210
Pubmed	SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract: A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2.	SMARCA2 SMARCA4	5.49e-06	2	82	2	26551623
Pubmed	Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer.	SMARCA4 EZH2	5.49e-06	2	82	2	33230143
Pubmed	SWI/SNF deficiency results in aberrant chromatin organization, mitotic failure, and diminished proliferative capacity.	SMARCA2 SMARCA4	5.49e-06	2	82	2	19458193
Pubmed	PRC2-mediated repression of SMARCA2 predicts EZH2 inhibitor activity in SWI/SNF mutant tumors.	SMARCA2 EZH2	5.49e-06	2	82	2	29087303
Pubmed	Two human homologues of Saccharomyces cerevisiae SWI2/SNF2 and Drosophila brahma are transcriptional coactivators cooperating with the estrogen receptor and the retinoic acid receptor.	SMARCA2 SMARCA4	5.49e-06	2	82	2	8208605
Pubmed	The Bromodomains of the mammalian SWI/SNF (mSWI/SNF) ATPases Brahma (BRM) and Brahma Related Gene 1 (BRG1) promote chromatin interaction and are critical for skeletal muscle differentiation.	SMARCA2 SMARCA4	5.49e-06	2	82	2	34289068
Pubmed	SMARCA4/2 loss inhibits chemotherapy-induced apoptosis by restricting IP3R3-mediated Ca2+ flux to mitochondria.	SMARCA2 SMARCA4	5.49e-06	2	82	2	34518526
Pubmed	SMARCA family of genes.	SMARCA2 SMARCA4	5.49e-06	2	82	2	32312722
Pubmed	Dual loss of the SWI/SNF complex ATPases SMARCA4/BRG1 and SMARCA2/BRM is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type.	SMARCA2 SMARCA4	5.49e-06	2	82	2	26356327
Pubmed	The Drosophila developmental gene fat facets has a human homologue in Xp11.4 which escapes X-inactivation and has related sequences on Yq11.2.	USP9X USP9Y	5.49e-06	2	82	2	8922996
Pubmed	Loss of BRG1/BRM in human lung cancer cell lines and primary lung cancers: correlation with poor prognosis.	SMARCA2 SMARCA4	5.49e-06	2	82	2	12566296
Pubmed	A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes.	SMARCA2 SMARCA4	5.49e-06	2	82	2	11163203
Pubmed	Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes.	SMARCA2 SMARCA4	5.49e-06	2	82	2	12620226
Pubmed	SMARCA2-deficiency confers sensitivity to targeted inhibition of SMARCA4 in esophageal squamous cell carcinoma cell lines.	SMARCA2 SMARCA4	5.49e-06	2	82	2	31406271
Pubmed	BRG1 and BRM SWI/SNF ATPases redundantly maintain cardiomyocyte homeostasis by regulating cardiomyocyte mitophagy and mitochondrial dynamics in vivo.	SMARCA2 SMARCA4	5.49e-06	2	82	2	27039070
Pubmed	Partial Inactivation of the Chromatin Remodelers SMARCA2 and SMARCA4 in Virus-Infected Cells by Caspase-Mediated Cleavage.	SMARCA2 SMARCA4	5.49e-06	2	82	2	29848589
Pubmed	Co-regulation of transcription by BRG1 and BRM, two mutually exclusive SWI/SNF ATPase subunits.	SMARCA2 SMARCA4	5.49e-06	2	82	2	29273066
Pubmed	Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.	HDAC3 SMARCA2 SMARCA4	5.63e-06	15	82	3	17255939
Pubmed	Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma.	USP9X SMARCA2 SMARCA4	6.92e-06	16	82	3	35390516
Pubmed	TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation.	SMARCA2 SMARCA4 EZH2	1.00e-05	18	82	3	28068325
Pubmed	The HDAC3-SMARCA4-miR-27a axis promotes expression of the PAX3:FOXO1 fusion oncogene in rhabdomyosarcoma.	HDAC3 SMARCA4	1.64e-05	3	82	2	30459282
Pubmed	Creatine kinase and creatine transporter in normal, wounded, and diseased skin.	CKMT2 CKMT1A	1.64e-05	3	82	2	11874479
Pubmed	Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.	SMARCA2 SMARCA4	1.64e-05	3	82	2	36464671
Pubmed	DNA damage sensitivity of SWI/SNF-deficient cells depends on TFIIH subunit p62/GTF2H1.	SMARCA2 SMARCA4	1.64e-05	3	82	2	30287812
Pubmed	The deubiquitinating enzyme Fam interacts with and stabilizes beta-catenin.	USP9X AFDN	1.64e-05	3	82	2	10620020
Pubmed	Differential effects of peroxynitrite on human mitochondrial creatine kinase isoenzymes. Inactivation, octamer destabilization, and identification of involved residues.	CKMT2 CKMT1A	1.64e-05	3	82	2	12401781
Pubmed	Maintained coupling of oxidative phosphorylation to creatine kinase activity in sarcomeric mitochondrial creatine kinase-deficient mice.	CKMT2 CKMT1A	1.64e-05	3	82	2	9618231
Pubmed	Molecular characterization of the creatine kinases and some historical perspectives.	CKMT2 CKMT1A	1.64e-05	3	82	2	9746319
Pubmed	Expression of the mitochondrial creatine kinase genes.	CKMT2 CKMT1A	1.64e-05	3	82	2	7808456
Pubmed	Pds5B is required for cohesion establishment and Aurora B accumulation at centromeres.	PDS5B PDS5A	1.64e-05	3	82	2	24141881
Pubmed	Histone deacetylase 3 is selectively involved in L3MBTL2-mediated transcriptional repression.	HDAC3 L3MBTL2	1.64e-05	3	82	2	20385135
Pubmed	Genome-wide association study identifies 5q21 and 9p24.1 (KDM4C) loci associated with alcohol withdrawal symptoms.	FSIP2 KDM4C	1.64e-05	3	82	2	22072270
Pubmed	The activity of p53 is differentially regulated by Brm- and Brg1-containing SWI/SNF chromatin remodeling complexes.	SMARCA2 SMARCA4	1.64e-05	3	82	2	17938176
Pubmed	Co-localization of FAM and AF-6, the mammalian homologues of Drosophila faf and canoe, in mouse eye development.	USP9X AFDN	1.64e-05	3	82	2	10704870
Pubmed	Functional redundancy of SWI/SNF catalytic subunits in maintaining vascular endothelial cells in the adult heart.	SMARCA2 SMARCA4	1.64e-05	3	82	2	22740088
Pubmed	BRCA1 interacts with dominant negative SWI/SNF enzymes without affecting homologous recombination or radiation-induced gene activation of p21 or Mdm2.	SMARCA2 SMARCA4	1.64e-05	3	82	2	15034933
Pubmed	TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.	SMARCA2 SMARCA4	1.64e-05	3	82	2	15075294
Pubmed	Pds5 Regulates Sister-Chromatid Cohesion and Chromosome Bi-orientation through a Conserved Protein Interaction Module.	PDS5B PDS5A	1.64e-05	3	82	2	28343969
Pubmed	A putative nuclear receptor coactivator (TMF/ARA160) associates with hbrm/hSNF2 alpha and BRG-1/hSNF2 beta and localizes in the Golgi apparatus.	SMARCA2 SMARCA4	1.64e-05	3	82	2	12044884
Pubmed	SWI/SNF complexes containing Brahma or Brahma-related gene 1 play distinct roles in smooth muscle development.	SMARCA2 SMARCA4	1.64e-05	3	82	2	21518954
Pubmed	Use of gene targeting for compromising energy homeostasis in neuro-muscular tissues: the role of sarcomeric mitochondrial creatine kinase.	CKMT2 CKMT1A	1.64e-05	3	82	2	9125373
Pubmed	Heterogeneous SWI/SNF chromatin remodeling complexes promote expression of microphthalmia-associated transcription factor target genes in melanoma.	SMARCA2 SMARCA4	1.64e-05	3	82	2	19784067
Pubmed	Octamers of mitochondrial creatine kinase isoenzymes differ in stability and membrane binding.	CKMT2 CKMT1A	1.64e-05	3	82	2	10748055
Pubmed	Separate nuclear genes encode sarcomere-specific and ubiquitous human mitochondrial creatine kinase isoenzymes.	CKMT2 CKMT1A	1.64e-05	3	82	2	2324105
Pubmed	Cardiac phenotype of mitochondrial creatine kinase knockout mice is modified on a pure C57BL/6 genetic background.	CKMT2 CKMT1A	1.64e-05	3	82	2	18948110
Pubmed	Characterization of mammary tumors from Brg1 heterozygous mice.	SMARCA2 SMARCA4	1.64e-05	3	82	2	17637742
Pubmed	Coordinated silencing of the Sp1-mediated long noncoding RNA MEG3 by EZH2 and HDAC3 as a prognostic factor in pancreatic ductal adenocarcinoma.	HDAC3 EZH2	1.64e-05	3	82	2	33299646
Pubmed	A quantitative approach to membrane binding of human ubiquitous mitochondrial creatine kinase using surface plasmon resonance.	CKMT2 CKMT1A	1.64e-05	3	82	2	11768757
Pubmed	BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression.	SMARCA2 SMARCA4	1.64e-05	3	82	2	20571081
Pubmed	Conserved SNH domain of the proto-oncoprotein SYT interacts with components of the human chromatin remodelling complexes, while the QPGY repeat domain forms homo-oligomers.	SMARCA2 SMARCA4	1.64e-05	3	82	2	14603256
Pubmed	SWI/SNF chromatin remodeling subunit Smarca4/BRG1 is essential for female fertility†.	SMARCA2 SMARCA4	1.64e-05	3	82	2	36440965
Pubmed	Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2.	SMARCA2 SMARCA4	1.64e-05	3	82	2	9099865
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	ZNF793 NRAP KLF10 ALMS1 ADAMTS9 SYNE2 NEB FHL1	2.32e-05	497	82	8	23414517
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	HDAC3 SH2D4A ALMS1 L3MBTL2 AFDN TTC17 FHL1 DYNC1H1 PDLIM5 PCMT1	3.25e-05	853	82	10	28718761
Pubmed	Dual role of NRSF/REST in activation and repression of the glucocorticoid response.	SMARCA2 SMARCA4	3.28e-05	4	82	2	17984088
Pubmed	Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma.	SMARCA2 SMARCA4	3.28e-05	4	82	2	31906887
Interaction	ABLIM2 interactions	SYNE2 AFDN FHL1 PDLIM5	2.19e-06	24	79	4	int:ABLIM2
Interaction	DGKG interactions	HDAC3 USP9X EZH2 DHTKD1	4.82e-06	29	79	4	int:DGKG
Interaction	H3C1 interactions	PDS5B HDAC3 FBLN1 RAD18 L3MBTL2 KDM4C MED14 SMARCA2 SMARCA4 PDS5A RRBP1 NEB EZH2 DYNC1H1	9.54e-06	901	79	14	int:H3C1
Interaction	KDM4C interactions	HDAC3 KDM4C USP9X SMARCA4 FHL1	1.21e-05	76	79	5	int:KDM4C
Interaction	BICD2 interactions	SH2D4A ALMS1 UBR3 AFDN TTC17 FHL1 DYNC1H1 PDLIM5 PCMT1	4.31e-05	426	79	9	int:BICD2
GeneFamily	LIM domain containing	NRAP FHL1 PDLIM5	8.97e-04	59	58	3	1218
GeneFamily	Trafficking protein particle complex	TRAPPC8 TRAPPC2L	8.98e-04	14	58	2	772
GeneFamily	PDZ domain containing	RHPN2 SYNPO2L AFDN PDLIM5	1.43e-03	152	58	4	1220
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS7 ADAMTS9	1.67e-03	19	58	2	50
CoexpressionAtlas	BM Top 100 - skeletal muscle	CKMT2 NRAP SYNPO2L FHL1 PDLIM5	8.29e-06	75	78	5	BM Top 100 - skeletal muscle
CoexpressionAtlas	BM Top 100 - heart atrium	CKMT2 FBLN1 NRAP SYNPO2L PDLIM5	1.07e-05	79	78	5	BM Top 100 - heart atrium
CoexpressionAtlas	BM Top 100 - tongue main corpus	CKMT2 NRAP SYNPO2L FHL1 PDLIM5	1.14e-05	80	78	5	BM Top 100 - tongue main corpus
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	NRAP PDE8B PAM NEB FHL1 PDLIM5	1.23e-06	188	81	6	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Slco3a1_(Slco3a1)-\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FSIP2 CKMT2 NRAP ASIC3	1.07e-05	75	81	4	574ed1836f6bf5fa38a53af0a05fa4437f68f36b
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr-Oligodendrocyte.Tfr.Slco3a1_(Slco3a1)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FSIP2 CKMT2 NRAP ASIC3	1.07e-05	75	81	4	45f7861bfeb1c6371b73cf2ea527801342e534bc
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 NRAP SYNPO2L PHYHIP NEB	1.56e-05	172	81	5	ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0
ToppCell	Influenza_Severe-CD4+_Tcm\|Influenza_Severe / Disease group and Cell class	TRIM31 PHYHIP AFDN FHL1 IL23R	1.56e-05	172	81	5	47865a04968ca28c6ff125159d9a23e37c8b8af1
ToppCell	facs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 NRAP SYNPO2L PHYHIP NEB	1.56e-05	172	81	5	bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FBLN1 CYP7B1 C2CD6 FHL1 DNAI3	1.99e-05	181	81	5	9ede19228ba5c0668a9c06c915510b95585216ef
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|LV / Chamber and Cluster_Paper	CKMT2 NRAP PAM FHL1 PDLIM5	2.16e-05	184	81	5	ab7a1620c14a9d9b6be1b47c559931e345e9eef8
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 NRAP SYNPO2L PHYHIP INPP5J	2.27e-05	186	81	5	337f768cc43db2db96ba6495b076006b1a5b0331
ToppCell	facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 NRAP SYNPO2L PHYHIP INPP5J	2.27e-05	186	81	5	e378c82ef6d6cb24751515aa499a01372b3e7ccf
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 ZFHX4 PAM FGFR1 FHL1	2.39e-05	188	81	5	2cfa41c64eccb28b5e22f0f91bbc921b75713245
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1-Tfr\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FSIP2 CKMT2 NRAP ASIC3	2.41e-05	92	81	4	0754a79efc4c0659d9a2acfe4185bcae1a3e7206
ToppCell	Substantia_nigra-Macroglia-OLIGODENDROCYTE-O1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FSIP2 CKMT2 NRAP ASIC3	2.41e-05	92	81	4	aee1fd2419dc1fc7039c0ac56f0ba23ed11d668f
ToppCell	droplet-Lung-immune-endo-depleted\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.45e-05	189	81	5	c3fb363bb0156ffb3367c200f548faebda64ab4a
ToppCell	droplet-Lung-immune-endo-depleted-3m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.45e-05	189	81	5	2a2953f6b1b7d070d739dcaf7285fce6e097d9e4
ToppCell	droplet-Heart-4Chambers-21m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 FBLN1 CPXM1 PAM FHL1	2.45e-05	189	81	5	2a5fda73d38bdc23cf47e5335ffd4e086e990245
ToppCell	droplet-Lung-3m\|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 CPXM1 PAM FGFR1 FHL1	2.45e-05	189	81	5	5a636e952da9b1fd26aa17f7b129054f2da322b5
ToppCell	droplet-Lung-immune-endo-depleted-3m-Mesenchymal\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.52e-05	190	81	5	9cd147a174017ebda23cc47b6d4552d898acd092
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SMARCA2 SMARCA4 PAM AFDN RRBP1	2.52e-05	190	81	5	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	droplet-Lung-nan-18m-Mesenchymal-Adventitial_Fibroblast\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 CYP7B1 FGFR1 FHL1	2.52e-05	190	81	5	97772e69e6f51ebffbb5433ca7b40f1048723220
ToppCell	droplet-Lung-nan-18m-Mesenchymal-adventitial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 CYP7B1 FGFR1 FHL1	2.52e-05	190	81	5	72c2b824acdc43139e6635785df3ed3feb58ec46
ToppCell	pdx-Tumor_cells-T1\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	PDS5B FBLN1 RAD18 EZH2 DDX11	2.52e-05	190	81	5	d06ee5f89f1cec8db6897fe3b2a890a07cd3697b
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBLN1 CPXM1 FGFR1 RRBP1 FHL1	2.58e-05	191	81	5	053b3664f509baa107feaf90730f80ebf9ac8f14
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBLN1 CPXM1 PAM FGFR1 RRBP1	2.58e-05	191	81	5	9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc
ToppCell	5'-Adult-LymphNode-Mesenchymal\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN1 ZFHX4 CPXM1 CYP7B1 FGFR1	2.58e-05	191	81	5	054e9a79bd1486fd812bc7418fb091664fe3a646
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 CPXM1 CYP7B1 FGFR1 FHL1	2.65e-05	192	81	5	1b228f0929b505de82a39bf64c837887b0e56701
ToppCell	5'-Adult-LymphNode-Mesenchymal-fibroblastic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FBLN1 ZFHX4 CPXM1 CYP7B1 FGFR1	2.65e-05	192	81	5	d7faa993f68e530ad55185505384ae155d36c222
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	USP9X PDS5A SMCR8 DYNC1H1 PUS7L	2.71e-05	193	81	5	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 CPXM1 CYP7B1 FGFR1 FHL1	2.71e-05	193	81	5	fe9720185929ef849edd1b8eb4854306b392e5a2
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FBLN1 CPXM1 PAM FGFR1 RRBP1	2.71e-05	193	81	5	051f61156b0e2e95292b2d8377faf3190b50f264
ToppCell	IPF-Epithelial-Mesothelial\|Epithelial / Disease state, Lineage and Cell class	ZFHX4 ADAMTS9 PHYHIP CPXM1 FGFR1	2.78e-05	194	81	5	d8a26da856a85e3d001d406e992cb18fdd58baef
ToppCell	facs-BAT-Fat-3m-Mesenchymal-mesenchymal_progenitor\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.78e-05	194	81	5	da45811ba07d746e7cba7ed78882b5d98ac7397d
ToppCell	droplet-Heart-nan-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.78e-05	194	81	5	20a0439fa02c5f8107612e34c7ab54120b9b8573
ToppCell	facs-BAT-Fat-3m-Mesenchymal\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.78e-05	194	81	5	76b8512fd92014b3ecc42b0a20d6d1df074cba2c
ToppCell	droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDS5B ADAMTS7 SMARCA4 PDS5A EZH2	2.78e-05	194	81	5	8ef0b71fef5b84cfd04973f891215333e7035d1d
ToppCell	RA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	NRAP PDE8B PAM DNAI3 PDLIM5	2.78e-05	194	81	5	89812fb164065041357bb37a3c2d87028ec3de4e
ToppCell	RA-03._Atrial_Cardiomyocyte\|RA / Chamber and Cluster_Paper	CKMT2 NRAP PDE8B PAM PDLIM5	2.78e-05	194	81	5	c3535f7cc0076653c72db582047cff053c322397
ToppCell	facs-BAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose\|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.78e-05	194	81	5	ef0fa9daecd3bf43c6cf56345928cacdbee19779
ToppCell	facs-Heart-LA-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.85e-05	195	81	5	79a6e8e6de040ff07539e8901fc407363a50e355
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l1\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 CPXM1 PAM FGFR1 FHL1	2.85e-05	195	81	5	773728703bc8969bff0e1de58fe3e1631add0a0a
ToppCell	facs-Heart-LA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.92e-05	196	81	5	8a84aeb1a565dd3e2a690fcaf1ab804f5e253545
ToppCell	facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.92e-05	196	81	5	ad1838dabd043cb140260843e3527d8c7d58850e
ToppCell	facs-Heart-LA-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.92e-05	196	81	5	cbc15c0769016fe9972445169029bd8d14a7e6ef
ToppCell	COVID-19-Heart-Mito_CM\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CKMT2 NRAP SYNPO2L NEB FHL1	2.99e-05	197	81	5	44e49943d62bfe622b40ad0460093d31540544df
ToppCell	facs-Heart-LA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 CPXM1 PAM FGFR1 FHL1	2.99e-05	197	81	5	2a91738cb6d7588869dd00deeea0cbbc2d6aa34d
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 ZFHX4 CPXM1 PAM RRBP1	2.99e-05	197	81	5	cfd4cc5fb8d7a60dd5c0d2a1a7bad7ba38c19d40
ToppCell	droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Scara5+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 ZFHX4 XDH FGFR1 FHL1	3.07e-05	198	81	5	d4f74320ea6c1a7e568ee5bc48bb66cb45e1004d
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FBLN1 ZFHX4 PAM FGFR1 FHL1	3.14e-05	199	81	5	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	Biopsy_Control_(H.)-Mesenchymal-Mesothelial_cells\|Biopsy_Control_(H.) / Sample group, Lineage and Cell type	FBLN1 ZFHX4 ADAMTS9 PHYHIP CPXM1	3.14e-05	199	81	5	ca970114b5aef4518ce580897a62ac88688b2671
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FBLN1 ZFHX4 PAM FGFR1 FHL1	3.14e-05	199	81	5	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	Bronchial_Biopsy-Mesenchymal-Fibroblasts\|Mesenchymal / Tissue, Lineage and Cell class of Lung Cells from 10X	FBLN1 FGFR1 RRBP1 FHL1	9.05e-05	129	81	4	13cd10ffdd8f1ef7721884e9efd2cf25f170f414
ToppCell	PBMC-Control-cDC_8\|Control / Compartment, Disease Groups and Clusters	TRIM31 C2CD6 ASIC3 SMCR8	1.75e-04	153	81	4	db1a6914f2033fb0748e0523cffe5d6dc4e901be
ToppCell	Bac-SEP-Lymphocyte-T_NK-CD4_TEM\|Bac-SEP / Disease, Lineage and Cell Type	WDR64 SYNE2 DNAI3 IL23R	1.88e-04	156	81	4	ef6bad99bcb30956863cd490c613e251f3b27ba0
ToppCell	Influenza_Severe-CD4+_Tcm\|World / Disease group and Cell class	TRIM31 PHYHIP AFDN FHL1	1.93e-04	157	81	4	842ac087d3d51dba3a6b6937733b73a81aa15e1b
ToppCell	facs-Heart-RV-24m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 NRAP ASIC3 DHTKD1	1.97e-04	158	81	4	2ef43d14ee65d004dc62c12ff209bbe12e4db681
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF550 ZFHX4 ADAMTS7 GRM7	2.02e-04	159	81	4	9f6607e395bcca9cb1c83199bdbbaaa62a93938d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZNF550 ZFHX4 ADAMTS7 GRM7	2.02e-04	159	81	4	c8b42ebc25ebcc450832096fbffaa5c5f5fe88e7
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	ZNF708 SYNE2 SMARCA2 USP9Y	2.17e-04	162	81	4	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	RAD18 FHL1 DHTKD1 DDX11	2.55e-04	169	81	4	563c267edaade0e5df192ad953801ef9768d4270
ToppCell	COVID-19-Heart-CM_+_Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CKMT2 NRAP FHL1 PDLIM5	2.61e-04	170	81	4	3f15242a1d3e4e9871d9170b2ef05842fb609c29
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	GABRG1 FBLN1 ACOT6 FHL1	2.61e-04	170	81	4	e20568c8f3f17d94de78229617eb2f7e4c5af2bc
ToppCell	facs-Heart-RV-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALMS1 ZFHX4 CPXM1 FGFR1	2.61e-04	170	81	4	d7c9a604311974ff87ece43a0f8725a234d262f7
ToppCell	3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VNN1 TRIM31 XDH RRBP1	2.67e-04	171	81	4	0de81d12a8000f2c59cdb214e67dc526d18098fe
ToppCell	3'-Adult-Distal_Rectal-Epithelial-mature_enterocytic-Colonocyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	VNN1 TRIM31 XDH RRBP1	2.67e-04	171	81	4	0597339618fb4d416d55c538eceb353218a55002
ToppCell	facs-Marrow-B-cells-24m-Hematologic-Unknown_Progenitor\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHPN2 RRBP1 NEB TRAPPC2L	2.73e-04	172	81	4	65b8935a972bf00b7a10dc2d442128fc0ed78bcb
ToppCell	droplet-Heart-nan-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 VNN1 CPXM1 FHL1	2.85e-04	174	81	4	cf4e0567f2a4ebe5534046b1c091af59b55bdc4f
ToppCell	facs-Skin-nan-24m-Epithelial-outer_bulge\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 PHYHIP FGFR1 DHTKD1	2.91e-04	175	81	4	f1166b567bca80dac3abe90c3dc544c831006640
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALMS1 ZFHX4 CPXM1 FGFR1	2.98e-04	176	81	4	c0a084f7a8645262d61971f094689e02bf15b113
ToppCell	T_cells-Tph_and_Tfh\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	SH2D4A PAM CYP7B1 FGFR1	2.98e-04	176	81	4	56c055488e34605d32562571a2fee621b47c9441
ToppCell	facs-Heart-RV-18m-Mesenchymal-fibroblast_of_cardiac_tissue\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ALMS1 ZFHX4 CPXM1 FGFR1	2.98e-04	176	81	4	cccf9201f6e2da7524b911a5961d3b227edab222
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS9 PHYHIP FGFR1 CKMT1A	3.04e-04	177	81	4	0912a291cff32a4ff8a2d7680ed1a1cd867fb90f
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	ZFHX4 SMARCA2 FGFR1 DNAI3	3.17e-04	179	81	4	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBLN1 CPXM1 PAM FGFR1	3.24e-04	180	81	4	9adebde5f4ca6dcb90e9113622862e14298465ac
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 CPXM1 FGFR1 ASIC3	3.24e-04	180	81	4	39ae8586efd91536e9ac6408d26de7e6d6237c41
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-skeletal_muscle_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 NRAP SYNPO2L NEB	3.24e-04	180	81	4	cea62fc006d68c3815c88bf17ec2617d7e41c3d2
ToppCell	COVID-19-Heart-CM_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CKMT2 NRAP FHL1 PDLIM5	3.31e-04	181	81	4	719eb532453ab7cd7893726885bc75d74a10b21e
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBLN1 CPXM1 FGFR1 FHL1	3.31e-04	181	81	4	091e7975badd1ffa463a8ec87908be20781ecfd6
ToppCell	critical-Myeloid-Mast_cell\|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	ADAMTS7 PROX2 FHL1 NSMCE1	3.31e-04	181	81	4	f0d81ae74d3f32979624a94b2ef93774831a7970
ToppCell	COVID-19-Heart-CM_3\|Heart / Disease (COVID-19 only), tissue and cell type	NRAP PAM FHL1 PDLIM5	3.38e-04	182	81	4	287fcc3897ae08841f6f85ae6c9cef16f75b1dd1
ToppCell	P28-Mesenchymal\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	FBLN1 CPXM1 FGFR1 FHL1	3.38e-04	182	81	4	69f9d44694fe4f55a971ae0ac5dc3e7448ee78f3
ToppCell	droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SH2D4A PHYHIP FGFR1 CKMT1A	3.38e-04	182	81	4	ccfee33de0faebbe69099d4ff3c3971f6a708b99
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	GABRG1 CKMT2 ADAMTS9 INPP5J	3.45e-04	183	81	4	2f0ee40e69ad1259e56e8ee4b352736900eb8901
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FBLN1 ZFHX4 FGFR1 FHL1	3.45e-04	183	81	4	12daaea821e49bc94a01e2496331e92a80d27339
ToppCell	COVID-19-Heart-CM_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	CKMT2 NRAP FHL1 PDLIM5	3.60e-04	185	81	4	549eeb521c3985bff396ea0f202db21822efa51f
ToppCell	LV-15._Ventricular_Cardiomyocyte_III\|World / Chamber and Cluster_Paper	CKMT2 NRAP FHL1 PDLIM5	3.60e-04	185	81	4	6baccb26f999145e51b91d94315bf8d4655bef31
ToppCell	droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49\|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 CFAP300 CPXM1 FHL1	3.60e-04	185	81	4	355b03c7ea438681e11a2b872c798c9ea26e1486
ToppCell	343B-Fibroblasts-Fibroblast-E-\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZNF708 ZNF793 FBLN1 CPXM1	3.67e-04	186	81	4	1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f
ToppCell	343B-Fibroblasts-Fibroblast-E\|343B / Donor, Lineage, Cell class and subclass (all cells)	ZNF708 ZNF793 FBLN1 CPXM1	3.67e-04	186	81	4	59db239f1864a5d4f1570c93219dbd7ac5b6db35
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SYNPO2L C2CD6 IL23R	3.74e-04	77	81	3	9a29879348b32b6c2302820f75fd55efba39aae8
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4-Inhibitory_Neuron.Gad1Gad2_Sst.Rbp4_(Interneuron,_OLM2_(CA1_enriched?))-\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SYNPO2L C2CD6 IL23R	3.74e-04	77	81	3	c5262a0d2040b2c580601e5a8d1ec626a0c7b560
ToppCell	Hippocampus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Rbp4\|Hippocampus / BrainAtlas - Mouse McCarroll V32	SYNPO2L C2CD6 IL23R	3.74e-04	77	81	3	3763b55e5ce44b844da661e9024c9f2c847ea26f
ToppCell	facs-Bladder-nan-24m-Epithelial-bladder_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 ZFHX4 FGFR1 FHL1	3.75e-04	187	81	4	2c145e9d11424939dd99012a8cedf5d998b966e9
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBLN1 ZFHX4 CPXM1 FHL1	3.82e-04	188	81	4	c32d023a69b6da79687ff8fa7485e7499db57046
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SH2D4A ADAMTS9 PAM AFDN	3.82e-04	188	81	4	43a3a59f92ad93509d4166bd025aed0b1b39a008
ToppCell	5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FBLN1 CPXM1 FGFR1 FHL1	3.82e-04	188	81	4	e18065bbc26d6f3774fd1f478fb41d8fb555fa26
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FBLN1 ZFHX4 CPXM1 FHL1	3.82e-04	188	81	4	1cd5a4d744bd3777246958ea5eb94388a5cbad81
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CKMT2 NRAP SYNPO2L INPP5J	3.90e-04	189	81	4	e758b264c0a47127e33e66c395cf5a3224c7305b
ToppCell	droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 ZFHX4 CPXM1 FHL1	3.90e-04	189	81	4	bc54ffd7bd1627a36747a80ce5139e4a69928400
ToppCell	droplet-Limb_Muscle-nan-21m-Mesenchymal-mesenchymal_stem_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FBLN1 ZFHX4 PAM FGFR1	3.90e-04	189	81	4	56f43e00d81cf3cdf0c39f8d7120f5beab72e258
ToppCell	facs-Lung-18m-Mesenchymal-fibroblast\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FBLN1 CPXM1 FGFR1 FHL1	3.90e-04	189	81	4	40cbd679dc0548bf5207e1b033c0597886ad6fe1
Drug	Methoxy-6-harmalan [3589-73-9]; Down 200; 18.6uM; MCF7; HT_HG-U133A	FBLN1 ALMS1 PDE8B MED14 SMARCA4 FGFR1 FHL1	6.18e-06	195	81	7	5455_DN
Drug	Nefopam hydrochloride [23327-57-3]; Up 200; 13.8uM; MCF7; HT_HG-U133A	FBLN1 ADAMTS7 CD101 SYNPO2L XDH CYP7B1 FGFR1	6.39e-06	196	81	7	4752_UP
Drug	Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A	FBLN1 MED14 FGFR1 RRBP1 NEB ADCY7 INPP5J	6.61e-06	197	81	7	5436_DN
Drug	rapamycin; Down 200; 0.1uM; MCF7; HG-U133A	PDE8B MED14 PDS5A FGFR1 RRBP1 PUS7L ZNF646	6.61e-06	197	81	7	326_DN
Drug	Dienestrol [84-17-3]; Down 200; 15uM; PC3; HT_HG-U133A	PDS5B FBLN1 KDM4C CYP7B1 FGFR1 RRBP1 ASIC3	6.83e-06	198	81	7	5727_DN
Drug	Felbinac [5728-52-9]; Up 200; 18.8uM; MCF7; HT_HG-U133A	FBLN1 SYNPO2L AFDN FGFR1 FHL1 GRM7 ZNF646	7.29e-06	200	81	7	3398_UP
Drug	Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A	CKMT2 ADAMTS7 PDE8B FGFR1 ASIC3 FHL1 GRM7	7.29e-06	200	81	7	6030_UP
Drug	DNFB	CKMT2 FBLN1 PAM XDH CKMT1A	3.68e-05	105	81	5	CID000006264
Drug	Lidocaone hydrochloride [73-78-9]; Down 200; 14.8uM; MCF7; HT_HG-U133A	FBLN1 XDH CYP7B1 RRBP1 NEB INPP5J	6.03e-05	190	81	6	4421_DN
Drug	Stachydrine hydrochloride; Down 200; 22.2uM; MCF7; HT_HG-U133A	FBLN1 PDE8B FGFR1 RRBP1 NEB FHL1	6.76e-05	194	81	6	2743_DN
Drug	Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A	FBLN1 ALMS1 TTLL1 FGFR1 FHL1 ADCY7	7.16e-05	196	81	6	4423_DN
Drug	Pheniramine maleate [132-20-7]; Down 200; 11.2uM; MCF7; HT_HG-U133A	FBLN1 PDE8B XDH FGFR1 NEB FHL1	7.16e-05	196	81	6	4130_DN
Drug	Naftifine hydrochloride [65473-14-5]; Down 200; 12.4uM; HL60; HT_HG-U133A	FBLN1 ALMS1 KDM4C CD101 FGFR1 PDLIM5	7.16e-05	196	81	6	2974_DN
Drug	Fenspiride hydrochloride [5053-08-7]; Up 200; 13.4uM; PC3; HT_HG-U133A	FBLN1 SMARCA2 PAM XDH PDS5A FGFR1	7.57e-05	198	81	6	2106_UP
Drug	PHA-00745360 [351320-33-7]; Up 200; 1uM; MCF7; HT_HG-U133A	CKMT2 XDH RRBP1 GRM7 INPP5J ZNF646	7.57e-05	198	81	6	4384_UP
Drug	Meclozine dihydrochloride [1104-22-9]; Up 200; 8.6uM; HL60; HT_HG-U133A	ZFHX4 MED14 CYP7B1 FGFR1 GRM7 INPP5J	7.57e-05	198	81	6	2424_UP
Drug	Oxalamine citrate salt [1949-20-8]; Down 200; 9.2uM; MCF7; HT_HG-U133A	FBLN1 SMARCA2 XDH TTLL1 RRBP1 NEB	7.78e-05	199	81	6	3344_DN
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A	NBAS SH2D4A ALMS1 PAM PDS5A RRBP1	7.78e-05	199	81	6	122_DN
Drug	PHA-00745360 [351320-33-7]; Down 200; 1uM; PC3; HT_HG-U133A	FBLN1 SH2D4A PDE8B CD101 CYP7B1 TTLL1	7.78e-05	199	81	6	4562_DN
Drug	Carbenoxolone disodium salt [7421-40-1]; Up 200; 6.6uM; MCF7; HT_HG-U133A	FBLN1 RRBP1 USP9Y FHL1 PDLIM5 ZNF646	7.78e-05	199	81	6	3353_UP
Drug	Nitrofural [59-87-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A	ALMS1 CYP7B1 AFDN TTLL1 FHL1 GRM7	7.78e-05	199	81	6	3320_UP
Drug	5149715; Up 200; 10uM; MCF7; HT_HG-U133A_EA	KDM4C TTLL1 RRBP1 NEB FHL1 INPP5J	7.78e-05	199	81	6	890_UP
Drug	AC1L1CQC	CKMT2 PHYHIP ASIC3 CKMT1A	8.53e-05	65	81	4	CID000002012
Drug	ATP gamma-(N-(2-chloroethyl)-N-methyl)amide	CKMT2 CKMT1A	1.24e-04	5	81	2	CID000174813
Drug	epoxycreatine	CKMT2 CKMT1A	1.24e-04	5	81	2	CID000194341
Drug	vibunazole	FHL1 PDLIM5	1.24e-04	5	81	2	CID000123676
Drug	gamma-benzylamide ATP	CKMT2 CKMT1A	1.24e-04	5	81	2	CID000194049
Drug	vitamin K1 diacetate	CKMT2 CKMT1A	1.24e-04	5	81	2	CID006441272
Drug	ATP gamma-p-azidoanilide	CKMT2 CKMT1A	1.24e-04	5	81	2	CID003035480
Drug	homocyclocreatine	CKMT2 CKMT1A	1.24e-04	5	81	2	CID000128636
Drug	N-2-hydroxyethyl-N-methyl-gamma-amide ATP	CKMT2 CKMT1A	1.24e-04	5	81	2	CID000195952
Drug	steroid U	CKMT2 CKMT1A	1.24e-04	5	81	2	CID000133659
Drug	gamma-anilide ATP	CKMT2 CKMT1A	1.24e-04	5	81	2	CID000193883
Disease	asparaginase-induced acute pancreatitis	NEB C3orf20 PDLIM5	1.59e-06	9	80	3	EFO_1001507
Disease	prostate cancer (is_marker_for)	KDM4C SMARCA2 SMARCA4 FGFR1 EZH2	6.76e-05	156	80	5	DOID:10283 (is_marker_for)
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	SMARCA2 SMARCA4	7.22e-05	5	80	2	C3281201
Disease	Emery-Dreifuss muscular dystrophy	SYNE2 FHL1	1.08e-04	6	80	2	cv:C0410189
Disease	Muscular Dystrophy, Emery-Dreifuss	SYNE2 FHL1	1.08e-04	6	80	2	C0410189
Disease	palmitoyl dihydrosphingomyelin (d18:0/16:0) measurement	SYNE2 SMARCA4	1.51e-04	7	80	2	EFO_0800400
Disease	X-Linked Emery-Dreifuss Muscular Dystrophy	SYNE2 FHL1	1.51e-04	7	80	2	C0751337
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCA2 SMARCA4	2.58e-04	9	80	2	DOID:0050340 (implicated_via_orthology)
Disease	endometriosis (implicated_via_orthology)	HDAC3 EZH2	3.93e-04	11	80	2	DOID:289 (implicated_via_orthology)
Disease	Major Depressive Disorder	XDH FGFR1 GRM7 ADCY7 PDLIM5	5.29e-04	243	80	5	C1269683
Disease	Coffin-Siris syndrome	SMARCA2 SMARCA4	5.55e-04	13	80	2	C0265338
Disease	Chromosome Breakage	EZH2 DDX11	6.47e-04	14	80	2	C0376628
Disease	Chromosome Breaks	EZH2 DDX11	6.47e-04	14	80	2	C0333704
Disease	non-high density lipoprotein cholesterol measurement	INTS10 FBLN1 LRFN2 PROX2 SYNE2 TRIM31 SMARCA4 PDS5A	7.01e-04	713	80	8	EFO_0005689
Disease	Synostotic Posterior Plagiocephaly	FGFR1 EZH2	8.50e-04	16	80	2	C1833340
Disease	Craniosynostosis, Type 1	FGFR1 EZH2	8.50e-04	16	80	2	C4551902
Disease	Acrocephaly	FGFR1 EZH2	8.50e-04	16	80	2	C0030044
Disease	Trigonocephaly	FGFR1 EZH2	8.50e-04	16	80	2	C0265535
Disease	Scaphycephaly	FGFR1 EZH2	8.50e-04	16	80	2	C0265534
Disease	Synostotic Anterior Plagiocephaly	FGFR1 EZH2	8.50e-04	16	80	2	C2931150
Disease	Metopic synostosis	FGFR1 EZH2	8.50e-04	16	80	2	C1860819
Disease	Brachycephaly	FGFR1 EZH2	9.61e-04	17	80	2	C0221356
Disease	level of Sphingomyelin (d32:1) in blood serum	SYNE2 SMARCA4	9.61e-04	17	80	2	OBA_2045173
Disease	phosphatidylcholine measurement	KDM4C VNN1 SYNE2 SMARCA4 DYNC1H1	1.06e-03	284	80	5	EFO_0010226
Disease	unipolar depression, memory performance, cognitive function measurement	TRIM31 TRAPPC8	1.34e-03	20	80	2	EFO_0003761, EFO_0004874, EFO_0008354
Disease	ulcerative colitis, Crohn's disease	ADCY7 IL23R	1.34e-03	20	80	2	EFO_0000384, EFO_0000729
Disease	Craniosynostosis	FGFR1 EZH2	1.34e-03	20	80	2	C0010278
Disease	stroke, coronary artery disease	ADAMTS7 SMARCA4	1.47e-03	21	80	2	EFO_0000712, EFO_0001645
Disease	HIV-1 infection, Susceptibility to viral and mycobacterial infections	KDM4C CYP7B1	1.47e-03	21	80	2	EFO_0000180, Orphanet_391311
Disease	breast carcinoma	INTS10 PDS5B NRAP L3MBTL2 KDM4C TRIM31 TTLL1 C2CD6 GRM7	1.74e-03	1019	80	9	EFO_0000305
Disease	descending aortic diameter	ADAMTS7 FHL1 PDLIM5	1.78e-03	88	80	3	EFO_0021788
Disease	myeloperoxidase measurement	SMG8 RRBP1	2.26e-03	26	80	2	EFO_0005243
Disease	serum alanine aminotransferase measurement	PDS5B RAD18 LRFN2 KLF10 ADAMTS7 ADAMTS9 XDH DDX11	2.45e-03	869	80	8	EFO_0004735
Disease	Malignant neoplasm of breast	CATSPERE SYNE2 KBTBD8 MED14 XDH FGFR1 TRAPPC8 EZH2 ZNF646	2.48e-03	1074	80	9	C0006142

Protein segments in the cluster

Peptide	Gene	Start	Entry
VHCLQSELNNYMPAF	AFDN	731	P55196
DKCPYMAFHNNVAHV	CATSPERE	581	Q5SY80
EQCKAPYVDHQMREN	ALMS1	2931	Q8TCU4
SSDPLDFQHHNYKAM	CPXM1	291	Q96SM3
ACVANTVAPLHYKDM	ACOT6	256	Q3I5F7
VNSDISCHYKNYPMH	PAM	216	P19021
CMPDNNFHSLYVKRH	ADCY7	261	P51828
AKLNDHLNNMAHYRP	DHTKD1	486	Q96HY7
EPESNKEAMYIRHCA	DNAI3	456	Q8IWG1
HVQCSHFDAMLYKGQ	ADAMTS7	601	Q9UKP4
FASHCLMNHPDLAKD	PDS5B	336	Q9NTI5
FASHCLMNHPDLAKD	PDS5A	346	Q29RF7
FVHMYNAQCDALHPK	RAD18	281	Q9NS91
LCRYMNNFDSEAHAK	INTS10	291	Q9NVR2
ATIAKNRNLHSPMYC	MC1R	61	Q01726
DSPDLVHAKNSYMHC	NRAP	1461	Q86VF7
DMAHHPTFRKIYCDA	L3MBTL2	396	Q969R5
FDECHNTSKQHPYNM	DDX58	371	O95786
NCRHFMPKISLQHYA	C2CD6	116	Q53TS8
NNCNLAYPMKSSHLR	FSIP2	2786	Q5CZC0
FANHSVNPNCYAKVM	EZH2	686	Q15910
FAHLPALMQHLADNY	PDE8B	851	O95263
EQEYNATVARMKPHC	KDM4C	631	Q9H3R0
QYKNCAHPAIDAMLR	ASIC3	346	Q9UHC3
PEEFNCAHCKNTMAY	PDLIM5	441	Q96HC4
KQAACPFYNHEQMGL	DDX11	311	Q96FC9
CFMYASDPAKQVSIH	GPR151	136	Q8TDV0
ALRFHDYKAASMHCQ	NBAS	1291	A2RRP1
IVFKPYQASQHDMCR	HDAC3	46	O15379
QDQCAKYMISHLDPQ	KBTBD8	136	Q8NFY9
EKPLQDMYNCLHSFC	MED14	286	O60244
NHYFCDMAPVIKLAC	OR10T2	176	Q8NGX3
AAMAYDRHAAICNPL	OR9G4	131	Q8NGQ1
NMHYNKGNDFEVPDC	PROX2	526	Q3B8N5
HRMATHQKDCSLPYA	FBLN1	41	P23142
DSAGMCYPSAKNHEQ	CFAP300	226	Q9BRQ4
MAEKFDCHYCRDPLQ	FHL1	1	Q13642
LGHVFNMPHDDNNKC	ADAMTS9	436	Q9P2N4
LQMKDAGEYECHTPN	CD101	111	Q93033
AECYLQLHNFPMDEH	GABRG1	186	Q8N1C3
GHRMDKPSNCTNELY	FGFR1	716	P11362
NNCPHGMAYDKRLNR	C3orf20	511	Q8ND61
HASMYCTAECPKHFQ	IL23R	96	Q5VWK5
QYPQSQACKMSHVRD	DYNC1H1	626	Q14204
NHQTCPMKAASILNY	KLF10	166	Q13118
ALHHMNKDLCADYRG	GRM7	421	Q14831
NHDMNDELHLCYQFL	CYP7B1	131	O75881
MHLPCVAKYFQSNAE	NSMCE1	211	Q8WV22
AEYPDLRKHNNCMAS	CKMT1A	51	P12532
SADYPDLRKHNNCMA	CKMT2	51	P17540
GPAFHKYAMQLHEDC	SMG8	541	Q8ND04
RHQPYQLKTAMFCFD	SYNPO2L	851	Q9H987
MALNPHCKFHIYNGT	USP9X	176	Q93008
VMLATDRSHYAKCNP	PCMT1	31	P22061
KEATCPRHQEMFHYF	TRIM31	91	Q9BZY9
RKLHNSYTDVMCNPF	TRAPPC2L	101	Q9UL33
QLRKICNHPYMFQHI	SMARCA2	1011	P51531
SCPEHHYKQMEGDRN	SYNE2	6461	Q8WXH0
LCEYAVAMKNLADNH	BMT2	71	Q1RMZ1
KHPCNLSYQLMEDHD	PUS7L	646	Q9H0K6
QLRKICNHPYMFQHI	SMARCA4	1041	P51532
HARTHCGNMLQPYLK	PHYHIP	151	Q92561
DHQEKCLSQLYDHMP	RHPN2	376	Q8IUC4
RPFCMAYISADQHKI	SMCR8	151	Q8TEV9
FLNCHLPAHMDKAEQ	INPP5J	556	Q15735
SLQKYMEHHCPNARL	ZFHX4	91	Q86UP3
SHCEKAFTQNPALMY	ZNF793	191	Q6ZN11
LCCHLSYKMSENIPN	VNN1	361	O95497
EKHMAAASAECQNYA	RRBP1	1206	Q9P2E9
CPKTYSNRMALKDHQ	ZNF646	1331	O15015
MGEHHLDKPYDVLCN	SH2D4A	81	Q9H788
RALFHMDNCYKIPNI	XDH	881	P47989
DHQEKCLSQLYDHMP	RHPN2P1	291	A8MT19
AMALNPHCKFHIYNG	USP9Y	176	O00507
DCLRQALHYAPHQMK	TTC17	1036	Q96AE7
CAEAFYLMPHLNRHQ	ZIM2	361	Q9NZV7
AMCSHFAKDLRPEQY	ZNF708	76	P17019
HQRVHTGMKPYECNA	ZNF550	221	Q7Z398
QSHFCNSMIDPDIYL	UBR3	701	Q6ZT12
LQSMPALDHEFLNHY	TRAPPC8	131	Q9Y2L5
VAPVMNNDKHCFECY	TTLL1	296	O95922
SSQENYFVIKPMDHC	WDR64	196	B1ANS9
RYKVCNHEAPSKMAA	LRFN2	556	Q9ULH4
EDPYHTHCMKVAAQN	NEB	686	P20929